SCHEMBL21496785

SCHEMBL21496785

CC(=O)N[C@@H](CCc1ccccc1)CN(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
HTT P42858 1/20 0.50
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HPGD P15428 1/20 0.47
CNR2 P34972 1/20 0.45
TSHR P16473 1/20 0.45
CTRB1 P17538 5/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
HSP90AA1 P07900 1/20 0.45
CTSG P08311 1/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21496788 1.00 SMN1; SMN2 (0.50) SMN1; SMN2KMT2AMEN1HTTALDH1A1
SCHEMBL23116580 0.84 CTRB1 (0.54) NPC1RAB9ACTRB1
SCHEMBL23116581 0.84 CTRB1 (0.54) NPC1RAB9ACTRB1
SCHEMBL15958711 0.83 SMN1; SMN2 (0.50) SMN1; SMN2KMT2AMEN1HTTALDH1A1
SCHEMBL10792660 0.80 MTNR1A (0.51) SMN1; SMN2KMT2AMEN1HTTALDH1A1
SCHEMBL13061188 0.79 TAAR1 (0.47) ALDH1A1TSHR
SCHEMBL13061073 0.79 TAAR1 (0.47) ALDH1A1TSHR
SCHEMBL28689707 0.78 KMT2A (0.49) SMN1; SMN2KMT2AMEN1HTTALDH1A1
SCHEMBL13061110 0.78 TAS1R3 (0.57) SMN1; SMN2KMT2AMEN1HTTALDH1A1
SCHEMBL5362381 0.78 CTRB1 (0.60) SMN1; SMN2KMT2AMEN1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112312902-B Pd (II) -catalyzed enantioselective C-H arylation of free carboxylic acids 斯克里普斯研究学院 2022-02-18 CN disclosed
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-01 US disclosed
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE 2021-03-25 US disclosed
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE 2021-03-25 US disclosed
CN-112312902-A Pd (II) -catalyzed enantioselective C-H arylation of free carboxylic acids 斯克里普斯研究学院 2021-02-02 CN disclosed
WO-2019204477-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE (US) 2019-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids PDCD1, PDK3, PDCD1LG2 SMN1; SMN2 3275/4885KMT2A 647/4885MEN1 4047/4885
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS PDCD1, PDK3, PDCD1LG2 SMN1; SMN2 3196/4885KMT2A 653/4885MEN1 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.